• mv-slider
  • lazy: true
HOME
サブ-ナビゲーション
  • information
  • News
  • Corporate Guide
  • Business
  • Investor Relations
  • Sustainability
  • Contact Us

HOME

NEWS

  • What’s new
  • Press Release
  • Investor Relations
  • Information
  • 2026/06/23 Update on Discussions on the Succession of the GMP-Compliant Cell Processing CDMO Business
  • 2026/06/23 Execution of a Patent License Agreement with 10x Genomics, Inc. for Spatial Products “Seeker™” and “Trekker™”
  • 2026/06/11 Notice of Delisting of Company Shares pdf （104KB）
  • 2026/05/20 Notice regarding Resolutions to Approve Share Consolidation, Abolition of Provision on Share Units, and Partial Amendment of AOI pdf （214KB）
  • 2026/05/13 Implementation of Structural Reforms for Profit Improvement pdf （183KB）
  • Read More
  • 2026/06/23 Update on Discussions on the Succession of the GMP-Compliant Cell Processing CDMO Business
  • 2026/06/23 Execution of a Patent License Agreement with 10x Genomics, Inc. for Spatial Products “Seeker™” and “Trekker™”
  • 2026/02/06 Waskyra™, a Gene Therapy Manufactured Using RetroNectin®, Receives U.S. and EU Marketing Authorization Approvals
  • 2025/09/16 Completion of Clinical Trial Notification Process in Japan for Confirmatory Study of NY-ESO-1・siTCR™ Gene Therapy
  • 2025/09/12 Announcement of “Takara Bio Group Long-Term Vision 2050”
  • Read More
  • 2026/06/11 Notice of Delisting of Company Shares pdf （104KB）
  • 2026/05/20 Notice regarding Resolutions to Approve Share Consolidation, Abolition of Provision on Share Units, and Partial Amendment of AOI pdf （214KB）
  • 2026/05/13 Implementation of Structural Reforms for Profit Improvement pdf （183KB）
  • 2026/05/13 Consolidated Financial Results for the Fiscal Year Ended March 31, 2026 (Under Japanese GAAP) pdf （560KB）
  • 2026/05/08 [Correction] Notice of the Convening of an Extraordinary General Meeting of Shareholders. pdf （175KB）
  • Read More
  • 2026/05/07 Takara Bio to Present Latest Advances in Gene and Cell Therapy at ASGCT 2026
  • 2024/05/02 Takara Bio to Present Advances in Gene and Cell Research at ASGCT 2024
  • Read More

BUSINESS

  • Read More

Research reagents

Scientific instruments

CDMO

Gene Therapy

SUSTAINABILITY

  • Read More

COMPANY

  • Read More

PAGETOP
PAGETOP
  • CLOSE
  • MENU

サイト内検索

  • footer-content
  • menu
  • JA
  • EN
  • contact
  • gnavi-box